NCT04648033 2026-01-29
ARCADIAN
University of Oxford
Phase 1 Completed
Clinical Trials
75 trialsNCT02998528 2026-01-06
CheckMate 816
Bristol-Myers Squibb
Phase 3 Completed
NCT00354393 2025-07-15
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
The Cleveland Clinic
Phase 2 Completed
NCT00540982 2025-07-02
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
City of Hope Medical Center
Phase 1/2 Completed
NCT02489903 2025-03-17
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
Phase 2 Completed
NCT00324805 2025-03-03
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT02892123 2024-11-27
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Jazz Pharmaceuticals
Phase 1 Completed
NCT00309998 2024-10-29
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Rochester
Phase 2 Completed
NCT03191786 2024-10-23
IPSOS
Hoffmann-La Roche
Phase 3 Completed
NCT02352948 2024-07-26
ARCTIC
AstraZeneca
Phase 3 Completed
NCT02709720 2024-01-11
NORA
Spanish Lung Cancer Group
Phase 2 Completed
NCT00602797 2023-09-26
Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer
University of Nebraska
Phase 2 Completed
NCT03345810 2023-06-15
DURATION
AIO-Studien-gGmbH
Phase 2 Completed
NCT02555007 2022-11-17
NVB Metro
Assistance Publique Hopitaux De Marseille
Phase 1 Completed
NCT00887783 2022-05-17
NARLAL
Odense University Hospital
Phase 2 Completed
NCT03801304 2022-05-12
VinMetAtezo
University Hospital, Brest
Phase 2 Completed
NCT02139904 2021-10-12
VIM
Wales Cancer Trials Unit
Phase 2 Completed
NCT02610140 2020-11-04
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
Bayer
Phase 2 Completed
NCT00002583 2020-04-03
Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
Canadian Cancer Trials Group
Phase 3 Completed
NCT03652857 2020-02-17
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2 Completed
NCT02603003 2019-09-20
CTC-TCM-FZ
Shanghai University of Traditional Chinese Medicine
Phase 1 Completed
NCT01848613 2018-11-09
VIVOS
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 4 Completed
NCT02619929 2018-08-29
StepUp
Pierre Fabre Pharma GmbH
Completed
NCT01443078 2018-08-09
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00287963 2018-05-17
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Medical University of South Carolina
Phase 1 Completed
NCT01029678 2018-05-03
RACCOSA
University Hospital, Limoges
Phase 2 Completed
NCT00215930 2017-03-23
The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00842712 2017-01-13
CERTO
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
NCT00773188 2016-11-02
A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.
Hoffmann-La Roche
Phase 1 Completed
NCT00683514 2016-10-04
Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT00755170 2016-10-04
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer
Hellenic Oncology Research Group
Phase 2 Completed
NCT00496275 2016-08-26
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC
Sanofi
Phase 1 Completed
NCT00008333 2016-07-13
Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01155258 2016-06-13
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
University of Southern California
Phase 1 Completed
NCT00198432 2016-03-10
Chemoradiotherapy of NSCLC Stage IIIB
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
NCT01684111 2016-01-18
VENUS-1
Aktion Bronchialkarzinom e.V.
Phase 1 Completed
NCT00401609 2016-01-14
G-Step
National Cancer Institute, Naples
Phase 1/2 Completed
NCT01109524 2015-12-24
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Eli Lilly and Company
Phase 2 Completed
NCT00675597 2015-11-20
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01196078 2015-07-27
A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed
NCT01209520 2015-02-24
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
University of Miami
Phase NA Completed
NCT01683682 2015-01-26
VENUS-2
Aktion Bronchialkarzinom e.V.
Phase 1 Completed
NCT00193921 2014-08-04
Chemoradiotherapy in Patients With Localised Lung Cancer
Trans Tasman Radiation Oncology Group
Phase 2 Completed
NCT00148798 2014-06-25
FLEX
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT00620971 2014-06-25
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
Hellenic Oncology Research Group
Phase 2 Completed
NCT00005865 2014-01-06
Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00253591 2013-12-19
Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT00003159 2013-12-04
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00870532 2013-11-04
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer
National Cancer Centre, Singapore
Phase 1 Completed